Shankar Ramaswamy, Kriya Therapeutics CEO

Kriya Ther­a­peu­tics buys sci­en­tif­ic ad­vi­sor’s NASH gene ther­a­py com­pa­ny

Shankar Ra­maswamy’s Kriya Ther­a­peu­tics has ac­quired an­oth­er gene ther­a­py start­up for an undis­closed amount.

Kriya has pur­chased Tra­mon­tane Ther­a­peu­tics, a chron­ic liv­er dis­ease gene ther­a­py …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.